Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
41.03B | 39.29B | 36.60B | 35.67B | 36.80B | Gross Profit |
8.36B | 6.55B | 7.47B | 7.27B | 7.48B | EBIT |
4.37B | 2.54B | 6.34B | 5.65B | 4.07B | EBITDA |
4.37B | 4.23B | 7.68B | 8.73B | 5.59B | Net Income Common Stockholders |
4.17B | 2.06B | 4.90B | 7.00B | 3.19B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.35B | 3.11B | 2.58B | 3.53B | 4.91B | Total Assets |
49.36B | 46.54B | 43.76B | 42.58B | 44.47B | Total Debt |
1.80B | 15.68B | 14.70B | 14.37B | 16.35B | Net Debt |
-2.56B | 12.57B | 12.12B | 10.84B | 11.44B | Total Liabilities |
34.07B | 31.75B | 28.44B | 29.65B | 33.89B | Stockholders Equity |
15.29B | 14.79B | 15.31B | 12.93B | 10.58B |
Cash Flow | Free Cash Flow | |||
2.62B | 2.10B | 1.47B | 2.15B | 2.88B | Operating Cash Flow |
4.39B | 3.88B | 2.90B | 3.57B | 4.30B | Investing Cash Flow |
-1.75B | -1.58B | -1.24B | 2.06B | -1.21B | Financing Cash Flow |
-1.40B | -1.76B | -2.61B | -7.00B | -432.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $67.14B | 16.37 | 27.30% | 1.70% | 4.44% | 110.33% | |
75 Outperform | $68.68B | 18.64 | 17.14% | 2.23% | 12.88% | 13.78% | |
74 Outperform | $105.65B | 20.12 | 84.26% | 2.82% | 5.14% | -19.14% | |
71 Outperform | $38.81B | 26.17 | 7.70% | 2.23% | 9.82% | 22.33% | |
64 Neutral | $13.64B | 17.26 | 11.44% | 0.11% | 0.14% | -5.38% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% | |
50 Neutral | $130.99B | ― | -162.23% | ― | -14.49% | -399.90% |
On February 18, 2025, Northrop Grumman’s Board approved compensation-related actions for its executives, setting 2025 goals under the Incentive Compensation Plan with financial and non-financial metrics. The Board also awarded Restricted Performance Stock Rights and amended the Severance Plan to reduce the severance timeframe and adjust bonus determination. Additionally, Graham Robinson announced he will not seek re-election to the Board at the 2025 Annual Meeting.